Linagliptin and Metformin Hydrochloride "'"'''

Linagliptin and Metformin Hydrochloride 
LINALIGLIP 2.5/500  are two different medications often used together to manage diabetes, particularly type 2 diabetes. They work in distinct ways to help control blood sugar levels.
Linagliptin is a medication classified as a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the DPP-4 enzyme, which breaks down incretin hormones. Incretin hormones play a role in regulating blood sugar by stimulating the release of insulin and reducing the production of glucagon after meals. By inhibiting DPP-4, linagliptin increases the availability of these incretin hormones, which helps lower blood sugar levels.
Metformin Hydrochloride is a widely used oral antidiabetic medication, and it belongs to a class called biguanides. Metformin primarily works by reducing the amount of sugar produced by the liver and improving the body's sensitivity to insulin, which helps the cells take up and use sugar more effectively. This leads to lower blood sugar levels.
The combination of LINALIGLIP 2.5/500  is often prescribed to individuals with type 2 diabetes when diet and exercise alone are insufficient to control their blood sugar levels. These medications can complement each other's mechanisms of action, providing better glucose control. It is usually available as a combination tablet containing both LINALIGLIP 2.5/500 , making it more convenient for patients to take both medications.
For further information please contact:
info@sterispharma.com
Order Now - https://www.sterisonline.com/product/linaliglip-2-5-500-134273